The U.S. Food and Drug Administration (FDA) is preparing to ban compound pharmacies from producing alternative versions of popular weight loss medications like Ozempic. This change could affect many people who rely on these more affordable options.
Justin Ceravolo, a pharmacist at Cypress Wellness Pharmacy, explained the impact of the ban, predicting a shortage within one to two months due to the drug’s popularity.
Compounded alternatives have been a more budget-friendly choice for many. While a box of four pre-filled syringes of brand-name drugs like Ozempic can cost over $1,200, a vial of the compounded version is several hundred dollars cheaper.
The affordability of these alternatives has driven a surge in their use, with an estimated 15.5 million Americans turning to them for weight loss. Users often buy these drugs at pharmacies, inject them at home, or visit local doctors or spas.
Shannon York Conrey, a nurse practitioner at a local medispa, administers these compounded shots to patients. “I see 20 to 30 patients a day,” Conrey said.
Studies show that these medications can help users lose up to 26% of their body weight, improving blood sugar levels and reducing obesity-related health issues such as high blood pressure and sleep apnea.
However, with the supply of compounded versions shrinking, some clients are becoming anxious. “People are desperate. They want this medication and are willing to do almost anything to get it,” Conrey added.
There is concern that patients might turn to unsafe alternatives in response to the shortage. Conrey said, “I’ve seen vials brought to me that were handwritten. I’ve heard of nail salons offering it in micro-doses.”
While brand-name prescriptions are available, some patients who have already lost weight may no longer qualify for them. “We are also under regulations not to prescribe to patients outside the proper parameters,” Conrey noted.
Dr. Robert Brueck, a board-certified plastic surgeon, raised concerns about the financial motivations driving the drug’s popularity. “The driving force behind this is money. The goal is to make millions, and sometimes patient health is sacrificed,” said Brueck. “We want what’s best for the patient.”
As the situation unfolds, individuals must remain patient with their weight loss journey.
